IDTF-thumbnail
IDTF-thumbnail
ID the Future Intelligent Design, Evolution, and Science Podcast
Episodes
Share
Facebook
Twitter
LinkedIn
Flipboard
Print
Email

Michael Behe: Vindication for ‘The Edge of Evolution’

Guest
Michael Behe
Duration
00:11:49
Download
Audio File (9.8 mb)
Share
Facebook
Twitter
LinkedIn
Flipboard
Print
Email

On this episode of ID the Future, Dr. Michael Behe talks with Casey Luskin about recent findings that support his argument in The Edge of Evolution. Dr. Behe explains why Chloroquine, a drug that treats malaria, presents a good opportunity to study the limits of random mutation and natural selection, and how his conclusions inspired so much backlash — including misrepresentation of his argument — from his critics.

Michael J. Behe

Senior Fellow, Center for Science and Culture
Michael J. Behe is Professor of Biological Sciences at Lehigh University in Pennsylvania and a Senior Fellow at Discovery Institute’s Center for Science and Culture. He received his Ph.D. in Biochemistry from the University of Pennsylvania in 1978. Behe's current research involves delineation of design and natural selection in protein structures. In his career he has authored over 40 technical papers and three books, Darwin Devolves: The New Science About DNA that Challenges Evolution, Darwin’s Black Box: The Biochemical Challenge to Evolution, and The Edge of Evolution: The Search for the Limits of Darwinism, which argue that living system at the molecular level are best explained as being the result of deliberate intelligent design.
Tags
The Edge of Evolution